Recursion Pharmaceuticals, Inc. (RXRX)
3.185
-0.14
(-4.35%)
USD |
NASDAQ |
Nov 13, 16:00
3.16
-0.02
(-0.78%)
After-Hours: 19:59
Recursion Pharmaceuticals Market Cap : 1.787B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.787B |
| November 12, 2026 | 1.868B |
| November 11, 2026 | 2.014B |
| November 10, 2026 | 1.992B |
| November 09, 2026 | 2.135B |
| November 06, 2026 | 1.975B |
| November 05, 2026 | 1.964B |
| November 04, 2026 | 2.177B |
| November 03, 2026 | 2.065B |
| November 02, 2026 | 2.149B |
| October 30, 2026 | 2.261B |
| October 29, 2026 | 2.379B |
| October 28, 2026 | 2.323B |
| October 27, 2026 | 2.163B |
| October 26, 2026 | 2.030B |
| October 23, 2026 | 1.976B |
| October 22, 2026 | 1.912B |
| October 21, 2026 | 1.944B |
| October 20, 2026 | 1.955B |
| October 19, 2026 | 1.928B |
| October 16, 2026 | 1.851B |
| October 15, 2026 | 2.222B |
| October 14, 2026 | 1.998B |
| October 13, 2026 | 2.048B |
| October 12, 2026 | 2.142B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.329B |
| October 08, 2026 | 2.110B |
| October 07, 2026 | 2.281B |
| October 06, 2026 | 2.473B |
| October 05, 2026 | 2.553B |
| October 02, 2026 | 2.201B |
| October 01, 2026 | 2.174B |
| September 30, 2026 | 2.206B |
| September 29, 2026 | 2.153B |
| September 28, 2026 | 1.976B |
| September 25, 2026 | 1.998B |
| September 24, 2026 | 2.078B |
| September 23, 2026 | 1.976B |
| September 22, 2026 | 2.163B |
| September 21, 2026 | 2.120B |
| September 18, 2026 | 2.046B |
| September 17, 2026 | 1.891B |
| September 16, 2026 | 1.704B |
| September 15, 2026 | 1.731B |
| September 14, 2026 | 1.821B |
| September 11, 2026 | 1.709B |
| September 10, 2026 | 1.688B |
| September 09, 2026 | 1.717B |
| September 08, 2026 | 1.837B |
| September 04, 2026 | 1.939B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Absci Corp. | 1.450B |
| Editas Medicine, Inc. | 333.44M |
| Twist Bioscience Corp. | 6.994B |
| Beam Therapeutics, Inc. | 2.362B |
| AbbVie, Inc. | 521.47B |
Market Cap Related Metrics
| PS Ratio | 24.87 |
| Price to Book Value | 1.973 |
| Price | 3.185 |
| Earnings Yield | -28.02% |